London, UK – In a significant move within the burgeoning plant-based and wellness sectors, UK-based investment firm Tooru has announced its agreement to acquire Mylky, a pioneering Belgian company specializing in at-home plant-based milk machines, for a sum of £12 million (approximately $16.2 million USD). This acquisition underscores Tooru’s strategic focus on the rapidly expanding wellness-focused consumer goods market and highlights Mylky’s substantial growth and market potential.
The deal, which is expected to be finalized within the next three months, will see Tooru take full ownership of Mylky. The transaction will be financed through a combination of Tooru’s existing cash reserves, new debt facilities, a £3 million (approximately $4 million USD) loan note, and £3 million in newly issued Tooru shares, valued at £17 million (approximately $23 million USD). Tooru has secured a three-month exclusivity period to conduct due diligence and complete the acquisition. Preliminary discussions with institutional debt providers have been positive, indicating a robust financing strategy.
Mylky, founded in early 2024 by CEO Martin Saunders and co-founder Isabella, has experienced what its leadership describes as "phenomenal growth" since its inception. The company’s core offering is an innovative machine that allows consumers to create a variety of plant-based milks, including oat, almond, cashew, and coconut, directly in their homes. The device boasts a capacity ranging from 750ml to 1.6 litres, depending on the jug size. The user-friendly operation involves adding ingredients to a filter basket and initiating a blend cycle, with the entire process taking approximately 60 seconds and eliminating the need for separate straining.
Addressing Consumer Demands for Cost, Convenience, and Clean Ingredients
The rise of plant-based milk alternatives has been a defining trend in global food consumption over the past decade. While supermarket shelves are now stocked with a wide array of options, consumers are increasingly seeking greater control over cost, ingredients, and environmental impact. Mylky’s at-home solution directly addresses these evolving demands.
A key advantage of the Mylky machine is its significant cost-effectiveness. The company estimates that producing a litre of oat milk at home using its device costs approximately 40 cents, a stark contrast to the premium pricing of many commercially available branded alternatives. Beyond the financial savings, the at-home production model drastically reduces waste associated with single-use packaging, such as cartons and plastic bottles, and mitigates the associated carbon footprint of transportation and manufacturing.
Furthermore, in an era where concerns about ultra-processed foods (UPFs) are at the forefront of consumer health consciousness, Mylky empowers individuals to tailor their plant-based milk to their exact preferences. This includes the ability to add natural sweeteners, fruits, spices, and other flavour enhancers, ensuring transparency and control over the ingredient list. Research in markets like the UK indicates that a significant driver for consumers to increase their intake of plant-based products is the availability of clear health information on packaging and confidence in the use of natural ingredients. Mylky’s approach directly aligns with this consumer desire for wholesome, minimally processed food and beverage options.
Financial Performance Reflects Strong Market Traction
Mylky’s rapid ascent is substantiated by its impressive financial performance. Management projections indicate that the company generated revenues of approximately £7.5 million (around $8.8 million USD) in 2025. The company’s operational efficiency and strong margins contributed to an Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of approximately £2.5 million (around $2.9 million USD) for the same period.
Early trading figures for the first quarter of 2026 have reportedly surpassed budget expectations, signaling a "significant uplift" compared to the previous year. For the trailing twelve months, revenue is on track to reach £9 million (approximately $10.6 million USD), with EBITDA projected at £3.1 million (approximately $3.5 million USD). This robust financial trajectory has undoubtedly been a key factor in attracting Tooru’s investment interest.
Tooru’s Strategic Vision: Expansion and Synergies
The acquisition of Mylky aligns perfectly with Tooru’s stated strategy of investing in and scaling businesses within the wellness and health-focused consumer goods space. Tooru, already a portfolio holder of established gluten-free brands such as Juvela and Oaf, and vegan snacking labels like Pulsin and Purely, views Mylky as a highly complementary addition.
The Belgian company boasts an active customer base exceeding 70,000 individuals across eight European countries, with Germany, France, and Switzerland representing its primary markets. Tooru identifies this substantial customer engagement as a testament to "strong brand loyalty" and a solid foundation for future growth, including repeat purchases and the introduction of new product lines.
Tooru anticipates significant expansion opportunities for Mylky, both within its existing European markets and through strategic entry into new territories, notably the UK. This expansion will be driven by the continued consumer shift away from dairy milk towards plant-based alternatives. Plans are already underway for short-term rollouts into several new international markets.
Furthermore, Tooru has identified numerous co-branding possibilities between Mylky and its existing portfolio brands. This could involve offering Mylky ingredients on a subscription basis, creating integrated product offerings, and leveraging cross-promotional activities.
"We are very excited about the opportunity to grow Mylky and to build it alongside Pulsin, Juvela, and OAF," stated Scott Livingston, CEO of Tooru. "We see many interesting ideas and innovation potential for home-based ‘free-from’ food and drink production and subscription/regime type offerings. The acquisition of this profitable business would both enhance and add scale to the Tooru group, [which] will help its public journey in the short term and create value for our shareholders. The team at Mylky are exceptional, and we all look forward to working together going forward. We believe that this is very much the first step in the implementation of our stated buy and build strategy."
A Broader Market Context: Consolidation in the Alternative Protein Sector
The acquisition of Mylky by Tooru is emblematic of a wider trend of consolidation within the alternative protein and plant-based food sectors. Over the past 18 months, the industry has witnessed a significant number of mergers, acquisitions, liquidations, and operational closures, with more than 70 companies reportedly affected. In the UK alone, notable acquisitions include Deliciously Ella, The Pack, Might Drinks, Happiness in Plants, and Julienne Bruno, among others. This consolidation suggests a maturation of the market, with established players seeking to acquire innovative startups or facing increased competitive pressure.
Following the completion of the acquisition, the Mylky leadership team is expected to transition to senior management roles within Tooru. This integration is poised to leverage the expertise of the Mylky team to drive future innovation and expansion. Mylky joins a competitive landscape of at-home plant-based milk makers, including established brands like Almond Cow, ChefWave, Nutr, Tribest, and NutraMilk, underscoring the growing consumer interest in this product category. The successful integration and strategic development of Mylky under Tooru’s ownership will be closely watched as a barometer of the ongoing evolution and consolidation within the global wellness and alternative food industries.